A Case of Myeloproliferative Neoplasm-Associated Glomerulopathy in a Patient With Myelofibrosis

Saskia Leibowitz1,2,3, Michelle Spanevello4, Leo Francis5

  • 1Nephrology Department Royal Brisbane and Women's Hospital Herston Queensland Australia.

Clinical Case Reports
|October 30, 2025
PubMed

Insights

Myeloproliferative neoplasm (MPN)-related glomerulopathy is a rare complication of MPN, often showing mesangial matrix expansion. Further research is needed to identify risk factors for this kidney condition.

Area of Science:

  • Nephrology
  • Hematology
  • Oncology

Background:

  • Myeloproliferative neoplasm (MPN)-related glomerulopathy is a rare renal complication.
  • Mesangial matrix expansion is the typical histopathological finding.
  • Proteinuria is not consistently observed in all cases.

Purpose of the Study:

  • To explore the characteristics of MPN-related glomerulopathy.
  • To investigate potential risk factors contributing to its development.

Main Methods:

  • Review of existing literature on MPN-related glomerulopathy.
  • Analysis of histopathological findings.
  • Correlation with clinical data.

Main Results:

  • Mesangial matrix expansion identified as a key histopathological feature.
  • Variability in proteinuria presence noted.
  • Need for further investigation into risk factors.

Conclusions:

  • MPN-related glomerulopathy is an uncommon but significant complication.
  • Understanding risk factors like disease type, mutations, and treatments is crucial.
  • Further research is warranted to guide clinical management and prevention strategies.